News
News
- Basilea reports positive interim results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene mutation- or amplification-positive patients with bile duct cancer (iCCA)
03/24/2021 / 07:15 - GlobeNewswire - Roche: Antibody cocktail 70% effective in preventing COVID deaths
03/23/2021 / 08:16 - TeleTrader - GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of GNMK and Encourages Investors to Contact the Firm
03/15/2021 / 18:57 - GlobeNewswire - Roche to acquire GenMark Diagnostics for $1.8 billion
03/15/2021 / 08:07 - TeleTrader - Trial of Roche's drug plus remdesivir didn't meet its endpoints
03/11/2021 / 08:51 - TeleTrader - CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2021 Annual Meeting
03/10/2021 / 23:03 - GlobeNewswire - 106 COVID VARIANTS IDENTIFIED IN 12 U.S. STATES
03/09/2021 / 18:19 - GlobeNewswire - Roche hopes to build pill against COVID by year end - CEO
03/09/2021 / 14:00 - TeleTrader - Gritstone Announces Promotions Within its Leadership Team
03/08/2021 / 14:00 - GlobeNewswire - Atea Pharmaceuticals Presents Favorable Phase 1 Results for AT-527 at 28th Annual Conference on Retroviruses and Opportunistic Infections
03/06/2021 / 13:00 - GlobeNewswire
Real-time